#antibody_fusion_protein
LightNews LightNews
huggenberg.substack.com
IL-15: from discovery to FDA approval

IL-15 is the first cytokine in over 30 years to receive FDA approval for the treatment of cancer.

#Immunotherapy #immunology #antibody_fusion_protein #IL-15 #immunosky

jhoonline.biomedcentral.com/articles/10....
IL-15: from discovery to FDA approval - Journal of Hematology & Oncology
jhoonline.biomedcentral.com
March 14, 2025 at 11:19 AM
huggenberg.substack.com
The transformation from #cancercare towards #Immunotherapy with a therapeutic #CancerVaccine across multiple tumor types.

#Lymphopenia #antibody_fusion_protein #NKcells

immunitybio.com/founders-vis...
March 6, 2025 at 7:58 AM
huggenberg.substack.com
New blood test routine:
Anemia —> Epogen
Neutropenia —> Neupogen
Lymphopenia —> Anktiva
#Immunotherapy #antibody_fusion_protein #NKcells #Lymphopenia #CARNK

#Anktiva mechanism of action

www.urologytimes.com/view/anktiva...
Anktiva as a lymphocyte rescue molecule: Unlocking the power of NK cells and T cells
"One way to think about how Anktiva works is it is the first molecule, based on the package insert, that increases and proliferates the NK cells, the T cells, and the CD4+ and CD8+ T cells, without up...
www.urologytimes.com
February 28, 2025 at 8:47 AM
huggenberg.substack.com
Former blood test routine:
Anemia —> Epogen
Neutropenia —> Neupogen

New blood test routine:
Anemia —> Epogen
Neutropenia —> Neupogen
Lymphopenia —> Anktiva

#Immunotherapy #antibody_fusion_protein #NKcells #Lymphopenia #CARNK

ir.immunitybio.com/news-release...
ImmunityBio Receives FDA RMAT Designation for ANKTIVA® and CAR-NK for the Reversal of Lymphopenia in Patients Receiving Standard-of-Care Chemotherapy/Radiotherapy and in Treatment of Multiply Relapsed...
Regenerative Medicine Advanced Therapy (RMAT) designation follows clinical data of Absolute Lymphocyte Count (ALC) and significant Overall Survival (OS) correlations in QUILT trials across multiple tu...
ir.immunitybio.com
February 28, 2025 at 8:38 AM
huggenberg.substack.com
Kick and Kill HIV Cure Strategy: Anktiva (N-803), an IL-15 superagonist, stimulates latent HIV replication in CD4+ cells (the kick) and increases immune cell activation (the kill).
www.youtube.com/watch?v=AfsM...
#immunology #antibody_fusion_protein
New HIV Cure Research: Anktiva's 'Kick & Kill' Strategy Explained!
YouTube video by ZOOM HOSPITAL
www.youtube.com
February 6, 2025 at 2:34 PM